SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BRAVEHEART who wrote (10)1/9/1999 4:44:00 PM
From: William Whitehead Jr.  Read Replies (1) of 423
 
Congradulations to all on such an informative and well documented web site.

Biotech's (and related) are near and dear to my heart - they comprise over 75% of my portfolio. I did close to 5 years of pre-med sciences at the U of T and while I may understand a lot of the science involved, I can't explain why so many are trading at such deep discounts to their actual cash value of near term projected revenue stream.

A few that I'm holding are: (in no necessary order of importance): Salix Pharm. (TSE:SLX), Biotech Holdings (ASE:BIO), Inex Pharm. (TSE:IEX), Ceapro (ASE:CZO), Hyal Pharm (TSE:HPC), Biomira (TSE:BRA),
Briana Biotech (VSE:BIA) ... and so on!

Reading the last few posts has provided insight into possibly others.
If I can help/share what I know please let me know.

Whitey,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext